Skip Content
You are currently on the new version of our website. Access the old version .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 21, Issue 4

2014 August - 21 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (21)

  • Editorial
  • Open Access
556 Views
3 Pages

1 August 2014

Early in clinical training, medical oncologists are taught that the goals of any palliative oncologic therapy include symptom control, quality-of-life improvement through disease stabilization, and prolongation of progression-free survival.[...]

  • Article
  • Open Access
152 Citations
6,040 Views
9 Pages

Information Needs and Sources of Information for Patients during Cancer Follow-Up

  • M.A. Shea–Budgell,
  • X. Kostaras,
  • K.P. Myhill and
  • N.A. Hagen

1 August 2014

(1) Background: Now more than ever, cancer patients want health information. Little has been published to characterize the information needs and preferred sources of that information for patients who have completed cancer treatment. (2) Methods: We u...

  • Article
  • Open Access
88 Citations
2,709 Views
7 Pages

1 August 2014

(1) Purpose: In the present study, we aimed to investigate the effects of chemotherapy-induced peripheral neurotoxicity (cipn) on psychological distress and sleep quality in cancer patients. (2) Methods: A total of 706 cancer patients were interviewe...

  • Article
  • Open Access
19 Citations
1,175 Views
6 Pages

1 August 2014

(1) Background: Adjuvant chemotherapy started more than 56 days after colon cancer resection has been associated with lesser overall survival among patients with stage iii colon cancer. The objective of the present population-based study was to deter...

  • Article
  • Open Access
20 Citations
1,220 Views
6 Pages

The Role of Palliative Chemotherapy in Hospitalized Patients

  • P. Wheatley–Price,
  • M. Ali,
  • K. Balchin,
  • J. Spencer,
  • E. Fitzgibbon and
  • C. Cripps

1 August 2014

Background: Hospitalized patients with advanced cancer often have a poor performance status, which is considered a relative contraindication to cytotoxic chemotherapy. We investigated outcomes in hospitalized solid tumour oncology patients who receiv...

  • Article
  • Open Access
12 Citations
986 Views
10 Pages

Protective Skin Care Behaviors in Cancer Survivors

  • S.C.M. Lau,
  • L. Chen and
  • W.Y. Cheung

1 August 2014

(1) Purpose: Research suggests that physicians neglect preventive care for cancer survivors. A survivor’s self-motivation with respect to preventive care is unknown. Using protective skin care as a proxy, our aims were to characterize preventive care...

  • Article
  • Open Access
23 Citations
1,162 Views
10 Pages

1 August 2014

Background: Combinations of chemotherapy regimens and monoclonal antibodies have been demonstrated to improve clinical outcomes in patients with metastatic colorectal cancer (MCRC). Although these combination treatment strategies are safe and effecti...

  • Article
  • Open Access
6 Citations
925 Views
6 Pages

18F-Fluorodeoxyglucose Positron-Emission Tomography Could Have a Prognostic Role in Patients with Advanced Hepatocellular Carcinoma

  • E. Simoneau,
  • M. Hassanain,
  • A. Madkhali,
  • A. Salman,
  • C.G. Nudo,
  • P. Chaudhury and
  • P. Metrakos

1 August 2014

(1) Introduction: We set out to evaluate the prognostic value of 18F-fluorodeoxyglucose positron-emission tomography (pet) in patients with advanced (non-transplant-eligible) hepatocellular carcinoma (hcc) and to evaluate the correlation between stan...

  • Article
  • Open Access
14 Citations
1,022 Views
7 Pages

1 August 2014

(1) Background: Almost 40% of people diagnosed with colorectal cancer will die from their disease, most with metastatic spread. When feasible, hepatic resection offers the greatest probability of cure for isolated liver metastases, but there are barr...

  • Article
  • Open Access
16 Citations
1,089 Views
9 Pages

1 August 2014

(1) Background: Impact factor (if) is often used as a measure of journal quality. The purpose of the present study was to determine whether trials with positive outcomes are more likely to be published in journals with higher ifs. (2) Methods: We rev...

  • Review
  • Open Access
109 Citations
2,600 Views
31 Pages

Bortezomib in Multiple Myeloma: Systematic Review and Clinical Considerations

  • T.C. Kouroukis,
  • F.G. Baldassarre,
  • A.E. Haynes,
  • K. Imrie,
  • D.E. Reece and
  • M.C. Cheung

1 August 2014

We conducted a systematic review to determine the appropriate use of bortezomib alone or in combination with other agents in patients with multiple myeloma (MM). We searched MEDLINE, EMBASE, the Cochrane Library, conference proceedings, and the refer...

  • Review
  • Open Access
25 Citations
997 Views
9 Pages

Computerized Prescriber Order Entry in the Outpatient Oncology Setting: From Evidence to Meaningful Use

  • V. Kukreti,
  • R. Cosby,
  • A. Cheung,
  • S. Lankshear and
  • the ST Computerized Prescriber Order Entry Guideline Development Group

1 August 2014

Background: Chemotherapy is an effective treatment in the fight against many cancers. Medication errors in oncology can be particularly serious given the narrow therapeutic window of antineoplastic drugs and their high toxicities. Computerized prescr...

  • Review
  • Open Access
34 Citations
915 Views
17 Pages

A Systematic Review of Active Treatment Options in Patients with Desmoid Tumours

  • X. Yao,
  • T. Corbett,
  • A.A. Gupta,
  • R.A. Kandel,
  • S. Verma,
  • J. Werier and
  • M. Ghert

1 August 2014

Introduction: We conducted a systematic review to determine the optimal treatment options in patients with desmoid tumours who have declined observational management. Methods: A search was conducted of the medline and embase databases (1990 to Septem...

  • Guidelines
  • Open Access
88 Citations
3,880 Views
12 Pages

Management of Hypersensitivity to Platinum- and Taxane-Based Chemotherapy: cepo Review and Clinical Recommendations

  • J. Boulanger,
  • J.N. Boursiquot,
  • G. Cournoyer,
  • J. Lemieux,
  • M.S. Masse,
  • K. Almanric,
  • M.P. Guay and

1 August 2014

(1) Background: Although antineoplastic agents are critical in the treatment of cancer, they can potentially cause hypersensitivity reactions that can have serious consequences. When such a reaction occurs, clinicians can either continue the treatmen...

  • Article
  • Open Access
21 Citations
1,391 Views
8 Pages

Treatment and Follow-Up Strategies in Desmoid Tumours: A Practice Guideline

  • M. Ghert,
  • X. Yao,
  • T. Corbett,
  • A.A. Gupta,
  • R.A. Kandel,
  • S. Verma and
  • J. Werier

1 August 2014

Objectives: We set out to determine the optimal treatment options—surgery, radiation therapy (RT), systemic therapy, or any combinations thereof—for patients with desmoid tumours once the decision to undergo active treatment has been made (that is, m...

  • Article
  • Open Access
8 Citations
2,053 Views
8 Pages

1 August 2014

Pancreatic cancer is the 4th leading cause of cancerrelated death. Complete surgical resection (CR0) is considered the only curative treatment. Most patients present with unresectable or borderline resectable disease. Many small phase i/ii trials hav...

  • Case Report
  • Open Access
15 Citations
873 Views
5 Pages

1 August 2014

In an 11-year-old boy with osteosarcoma in the proximal tibia (type iii), 2 cycles of dia chemotherapy (cisplatin, ifosfamide, doxorubicin) were administered preoperatively while epiphysiolysis was performed. Clinical response was determined to be co...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729